Login / Signup

A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer.

Arthi SridharHina KhanBinoy YohannanKok Hoe ChanNilansh KatariaSyed Hasan Jafri
Published in: Journal of clinical medicine (2024)
The therapeutic landscape of the management of stage III non-small cell lung cancer (NSCLC) has drastically evolved with the incorporation of immunotherapy and targeted therapy. Stage III NSCLC accounts for one-third of the cases and the treatment strategy of these locally advanced presentations are diverse, ranging from surgical to non-surgical options; with the incorporation of chemo-immunotherapy, radiation, and targeted therapies wherever applicable. The staging of this disease has also changed, and it is essential to have a strong multidisciplinary approach to do justice to patient care. In this article, we aim to navigate the nuanced approaches in the diagnosis and treatment of stage III NSCLC and expand on the evolution of the management of this disease.
Keyphrases